Kalydeco

Pharma

Vertex's Trikafta posted megablockbuster sales in 202

Vertex snared $7.57 billion in product revenues for 2021, signaling a 22% increase year over year.
Fraiser Kansteiner Jan 27, 2022 9:55am

Vertex CEO touts Trikafta launch in 'mic drop' earnings call

Jan 31, 2020 9:17am

Vertex is 'humming' with triple combo launch Trikafta underway

Oct 30, 2019 4:44pm

Vertex ushers in CF triple combo era with Trikafta approval

Oct 21, 2019 6:42pm

Vertex: NHS England will have to do better with CF drugs offer

Jul 17, 2018 12:15pm

Patients wait as Vertex, U.K. officials argue over Orkambi price

Jul 9, 2018 12:25pm